Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

(2015) Xian-Zhi Li et al.   CLINICAL MICROBIOLOGY REVIEWS

Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus

(2015) Rajmohan Rajamuthiah et al.   PLoS One

Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections

(2015) Shankar Thangamani et al.   Scientific Reports

Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus

(2013) Marie Pierre Otto et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Effects of Linezolid on Suppressing In Vivo Production of Staphylococcal Toxins and Improving Survival Outcomes in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia

(2013) Binh An Diep et al.   JOURNAL OF INFECTIOUS DISEASES

Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria

(2013) J. R. Morones-Ramirez et al.   Science Translational Medicine

Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen

(2013) Lorenza Favrot et al.   Nature Communications

Targeting Listeria Monocytogenes rpoA and rpoD Genes Using Peptide Nucleic Acids

(2013) Ruba A. Alajlouni et al.   Nucleic Acid Therapeutics

Targeting Essential Genes in Salmonella enterica Serovar Typhimurium with Antisense Peptide Nucleic Acid

(2012) Muhammad A. Soofi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Linezolid Is Superior to Vancomycin in Experimental Pneumonia Caused by Superantigen-Producing Staphylococcus aureus in HLA Class II Transgenic Mice

(2012) Melissa J. Karau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Linezolid Effects on Bacterial Toxin Production and Host Immune Response: Review of the Evidence

(2012) Binh An Diep et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione

(2012) Jun Lu et al.   FASEB JOURNAL

Postoperative Intraperitoneal 5-Fluoro-2′-Deoxyuridine Added to Chemoradiation in Patients Curatively Resected (R0) for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

(2011) Deirdre J. Cohen et al.   ANNALS OF SURGICAL ONCOLOGY

Silica-Antibiotic Hybrid Nanoparticles for Targeting Intracellular Pathogens

(2009) M. N. Seleem et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin‐ResistantStaphylococcus aureusInfections

(2009) Stan Deresinski   CLINICAL INFECTIOUS DISEASES

TargetingBrucella melitensiswith polymeric nanoparticles containing streptomycin and doxycycline

(2009) Mohamed N. Seleem et al.   FEMS MICROBIOLOGY LETTERS

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology

(2009) F. C. Tenover et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Staphylococcus aureus: new evidence for intracellular persistence

(2009) Christian Garzoni et al.   TRENDS IN MICROBIOLOGY

R -01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance

(2008) E. Skripkin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Outer membrane permeability and antibiotic resistance

(2008) Anne H. Delcour   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS